Handling immune-suppressive therapies during SARS-CoV-2 pandemic: insights from pediatric datasets
暂无分享，去创建一个
[1] G. Ghiggeri,et al. COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[2] U. Maggiore,et al. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium , 2020, American Journal of Transplantation.
[3] F. Scolari,et al. Kidney transplant patients with SARS-CoV-2 infection: The Brescia Renal COVID task force experience , 2020, American Journal of Transplantation.
[4] B. Rovin,et al. COVID-19: implications for immunosuppression in kidney disease and transplantation , 2020, Nature Reviews Nephrology.
[5] M. Marlais,et al. The severity of COVID-19 in children on immunosuppressive medication , 2020, The Lancet Child & Adolescent Health.
[6] G. Ghiggeri,et al. Risk of COVID‐19 in young kidney transplant recipients. Results from a single‐center observational study , 2020, Clinical transplantation.
[7] G. Appel,et al. How COVID-19 Has Changed the Management of Glomerular Diseases. , 2020, Clinical journal of the American Society of Nephrology : CJASN.
[8] Giacomo Grasselli,et al. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. , 2020, JAMA.
[9] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.